Publicaciones en colaboración con investigadores/as de Universidad Católica San Antonio (6)

2023

  1. Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10

2022

  1. Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect

    JCI Insight, Vol. 7, Núm. 19

  2. Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation

    International journal of molecular sciences, Vol. 23, Núm. 18

2017

  1. Chitosan as stabilizing agent for negatively charged nanoparticles

    Carbohydrate Polymers, Vol. 161, pp. 63-70

2012

  1. Histological changes in connective tissue of rat tails after bipolar radiofrequency treatment

    Histology and Histopathology, Vol. 27, Núm. 9, pp. 1231-1237